Steroid hormone biosynthesis in the adrenal cortex is controlled by the peptide hormone adrenocorticotropin (ACTH), which acts to increase intracellular cAMP and results in the activation of cAMP-dependent protein kinase A (PKA) and subsequent increase in steroidogenic gene transcription. Protein phosphorylation by PKA activates transcription of genes encoding steroidogenic enzymes; however the precise proteins which are phosphorylated remain to be determined. We have recently shown that phosphoprotein phosphatase (PP) activity is essential for cAMP-dependent transcription of the human CYP17 (hCYP17) gene in H295R adrenocortical cells. The aim of our current studies was to determine if inhibition of PP activity attenuates cAMP-dependent mRNA expression of other steroidogenic genes in H295R cells. Using various inhibitors of serine/threonine and tyrosine PPs, we examined the role of phosphatase activity on cAMP-dependent transcription of steroidogenic genes in the adrenal cortex. CYP11A, CYP11B1/2, CYP21, and adrenodoxin also require PP activity for cAMP-stimulated gene expression. Inhibition of both serine/threonine and tyrosine PP activities suppresses the cAMP-dependent mRNA expression of several steroidogenic genes, suggesting that a dual-specificity PP is essential for conveying ACTH/cAMP-stimulated transcription. We propose that PKA phosphorylates and activates a dual-specificity phosphatase, which mediates steroidogenic gene transcription in response to ACTH/cAMP.
Introduction
Steroid hormone biosynthesis in the adrenal cortex is controlled by the peptide hormone adrenocorticotropin (ACTH) and involves two distinct responses that can be separated temporally (Waterman & Bischof 1997 , Sewer & Waterman 2001 . A rapid, acute response in the biosynthesis of steroid hormones results from mobilization of cholesterol from lipid stores to the inner mitochondrial membrane. The longer term, chronic effect is to coordinately increase the transcription of all steroidogenic genes. Both the acute and chronic responses are mediated via a cAMP-dependent signaling pathway. Increased intracellular cAMP results in the activation of protein kinase A (PKA) and subsequent increase in steroid hormone production. During the acute response, an essential site of phosphorylation by PKA is cholesterol ester hydroxylase, which upon activation catalyzes the conversion of cholesterol esters to free cholesterol (Jefcoate et al. 1992) . PKA phosphorylation leading to the chronic response activates transcription of genes encoding steroidogenic enzymes (Waterman 1994 , Sewer & Waterman 2001 ; however the precise proteins which are phosphorylated are not known.
We have recently shown that phosphatase activity is essential for cAMP-dependent transcription of the human CYP17 (hCYP17) gene in H295R adrenocortical cells. Both the serine/ threonine phosphatase inhibitor okadaic acid (OA) and the tyrosine phosphatase inhibitor peroxyvanadate (PV) attenuated cAMP-dependent induction of endogenous hCYP17 mRNA expression and the luciferase activity of a hCYP17 promoter-reporter construct ). Moreover, we were able to show that the cAMP-inducible binding of steroidogenic factor (SF)-1, polypyrimidine tract-binding protein associated splicing factor (PSF), and p54 nrb to the hCYP17 promoter was inhibited by both OA and PV. In vivo labeling of H295R cells showed a decrease in the levels of 32 P-orthophosphate associated with SF-1 after cAMP stimulation, suggesting that SF-1 is dephosphorylated in response to ACTH/cAMP .
cAMP-induced increase in steroidogenic acute regulatory (StAR) protein mRNA in mouse adrenal tumor Y1 cells has been found to be dependent upon phosphoprotein phosphatase (PP) activity (Jones et al. 2000) . Similarly, ACTH has been shown to stimulate the phosphotyrosine phosphatase SHP2 in bovine adrenocortical cells (Rocchi et al. 2000) . Also in bovine adrenocortical cells, the prototypical morphological cell rounding observed upon treatment with ACTH or cAMP is blocked by the tyrosine phosphatase inhibitor sodium orthovanadate (Vilgrain et al. 1998) . It was hypothesized that the mechanism for cell detachment and disassembly of focal adhesions was mediated by PKA phosphorylation and activation of a PP(s) in response to increased intracellular cAMP (Vilgrain et al. 1998) .
Our demonstration of an essential role for dephosphorylation in conveying ACTH/cAMPdependent transcription of hCYP17 led us to wonder whether PP activity is required for the cAMP-dependent expression of all steroidogenic genes in the human adrenal cortex. The aim of our current studies was to determine if inhibition of PP activity attenuates cAMP-dependent mRNA expression of other steroidogenic genes in H295R cells. We show that inhibition of both serine/ threonine and tyrosine PP activities suppresses the cAMP-dependent mRNA expression of several steroidogenic genes, suggesting that a dual-specificity PP is essential for conveying ACTH/cAMP-stimulated transcription in H295R cells.
Materials and methods

Reagents
Dibutyryl cAMP and hydrogen peroxide were obtained from Sigma (St Louis, MO, USA). Okadaic acid (Haystead et al. 1989 , Hardie et al. 1991 , endothall (Li et al. 1993) , bpV(phen) (Posner et al. 1994) , dephostatin (Fujiwara et al. 1997 , Spessert et al. 2001 ), cypermethrin (El-Tawil & Abdel-Rahman 2001 , Spessert et al. 2001 , cylclosporine A (Fast et al. 1993 ) and sodium orthovanadate (Posner et al. 1994) were obtained from Calbiochem (San Diego, CA, USA). Peroxyvanadate was prepared by mixing equal concentrations (12 mM) of hydrogen peroxide with sodium orthovanadate prior to treatment.
Cell culture
H295R adrenocortical cells (Staels et al. 1993 , Rainey et al. 1994 were generously donated by Dr William E Rainey (University of Texas Southwestern Medical Center, Dallas, TX, USA) and cultured in Dulbecco's modified Eagle's/F12 (DME/F12) medium (Gibco/BRL, Gaithersburg, MD, USA) supplemented with 10% Nu-Serum I (Collaborative Biomedical Products, Bedford, MA, USA), 0·5% ITS Plus (Collaborative Biomedical Products), and antibiotics. Cells were subcultured onto 6-well plates and treated with dibutyryl cAMP (dbcAMP) in the presence or absence of PP inhibitors for periods ranging from 6 to 12 h. The PP inhibitors used were OA (5 to 25 nM), PV (5 to 25 µM), endothall (ENL; 0·1 to 100 µM), cypermethrin (CYN; 1 to 50 nM), cyclosporine A (CyA; 5 to 500 nM), dephostatin (DPN; 0·6 to 60 µM) and bpV(phen) (bpV; 0·1 to 10 µM).
RNA isolation, Northern blotting and hybridization conditions
Total RNA was prepared from treated cells by acid-phenol extraction (TRIzol, Invitrogen). RNA concentrations were determined by absorbance at 260 nm. For Northern blot assays (Sambrook et al. 1989) , RNA (10 µg) was fractionated by agarose (1%) gel electrophoresis in the presence of 5% formaldehyde and transferred to nylon transfer membrane filters (HybondTM-N+, Amersham). A 1·2 kB cDNA fragment of hCYP17 was used to detect hCYP17 mRNA expression. cDNA fragments for hCYP11A, hCYP21, and adrenodoxin were used to detect mRNA expression of the corresponding steroidogenic gene. 3 -Hydroxysteroid dehydrogenase (3 HSD) was detected using a PCR-generated probe. The 3 HSD-pUC18 plasmid contained exon 3 3 HSD and was generously donated by Dr Mitsuhiro Okamoto (Osaka University Medical School, Japan). A cDNA probe for both hCYP11B1 and hCYP11B2 (hCYP11B1/2) was a gift from Dr Rita Bernhardt (Universität des Saarlandes, Germany). Results were normalized to the content of glyceraldehyde-3-phosphate dehydrogenase (GAP) mRNA. cDNA probes were labeled with [ -32 P]dCTP by random primer labeling (Prime It II, Stratagene; La Jolla, CA, USA). Blots were hybridized overnight at 42 C in a 2 sodium citrate-sodium chloride (SSC) solution containing 50% formamide, 5 Denhardt's solution, 2% sodium dodecyl sulfate (SDS), 100 µg/ml denatured single-stranded salmon sperm DNA, and 32 P-labeled cDNA probes. The hybridized membranes were sequentially washed for 2 10 min in 2 SSC, 0·2% SDS and 2 5 min in 0·2 SSC, 0·2% SDS at 42 C. The amount of probe bound to the filter was quantified using a Molecular Dynamics (Sunnyvale, CA, USA) phosphorimager and ImageQuant software (Sunnyvale, CA, USA).
Statistical analysis
Data from Northern blots were expressed as the percentage of the mean of the control group in each experiment. All data presented graphically represent quantitative analysis of three experiments performed in triplicate. One-way analysis of variance and the Newman-Keuls test were used to determine differences among treatment groups.
Results
cAMP-dependent steroidogenic gene mRNA expression requires serine/threonine phosphatase activity
There are four major classes of serine/threonine specific PPs (Mumby & Walter 1993) . These include PP1, PP2A, PP2B (calcineurin) and PP2C. OA is a selective inhibitor of PP2A (Haystead et al. 1989 , Hardie et al. 1991 . We have shown that the cAMP-stimulated mRNA expression of hCYP17 in H295R cells is attenuated by inhibitors of PP activity . To determine if cAMP-mediated dephosphorylation was required for the mRNA expression of other steroidogenic genes expressed in the human adrenal cortex we treated H295R cells for 12 h with OA in the presence and absence of 1 mM dbcAMP, and isolated total RNA for Northern blotting. We probed for the mRNA expression of hCYP11A1, hCYP11B1/2, hCYP17, hCYP21, 3 HSD, and adrenodoxin (Adx). As shown in Fig. 1A , cAMP-stimulation significantly increased the mRNA expression for all adrenocortical steroidogenic genes examined. The mRNA expression of hCYP11A1 was induced 4·7-fold, whereas hCYP17 mRNA levels were increased 9·5-fold. Similarly, hCYP11B1/2, hCYP21, 3 HSD and Adx mRNA levels were increased 7·3-, 2·8-, 3·4-, and 2·6-fold respectively by dbcAMP. Co-administration of dbcAMP and OA (5 to 25 nM) suppressed cAMPdependent increases in mRNA of all steroidogenic genes in a dose-dependent manner (Fig. 1B) . ENL (Li et al. 1993) , another PP2A inhibitor, also attenuated the cAMP-dependent expression of all steroidogenic genes (Fig. 1C) .
We next tested the effect of PP2B inhibition on cAMP-stimulated steroidogenic gene expression. PP2B (calcineurin) action is Ca 2+ -dependent, and is specifically inhibited by CyA (Fast et al. 1993) . Cells were treated with dbcAMP in the presence and absence of 5 to 500 nM CyA for 12 h. Representative Northern blots are shown in Fig. 2 and revealed no significant effect of CyA on cAMP-stimulated steroidogenic gene mRNA expression. Similar results were also seen for CYN (El-Tawil & Abdel-Rahman 2001) , another PP2B inhibitor (data not shown). Thus, the serine/ threonine PP activity which is required for cAMP-mediated steroidogenic gene transcription in the human adrenal cortex is independent of Ca 2+ ions.
cAMP-mediated steroidogenic gene mRNA expression is also dependent on tyrosine phosphatase activity
Our previous findings also showed a role for protein tyrosine phosphatase (PTP) activity in mediating the cAMP-dependent transcription of hCYP17 Figure 1 Serine/threonine phosphatase inhibitors suppress cAMP-dependent transcription of multiple steroidogenic genes. H295R cells were treated with 1 mM dbcAMP with or without 5, 10, or 20 nM okadaic acid (OA) for 12 h then harvested for isolation of total RNA. Northern blotting and hybridization to cDNAs for hCYP11A1 (h11A1), hCYP11B1/2 (h11B1/2), hCYP17 (h17), hCYP21 (h21), 3β-hydroxysteroid dehydrogenase (3βHSD), adrenodoxin (Adx) and glyceraldehyde-3-phosphate dehydrogenase (GAP) were performed as described in Materials and methods. (A) Representative Northern blots showing endogenous steroidogenic gene mRNA expression from control, dbcAMP-, dbcAMP+25 nM OA-, and 25 nM OA-treated cells.
(B) Graphical depiction of phosphorimager scanning and normalization to GAP content of each sample (n=9). Data represent the mean of three experiments performed in triplicate. (C) Cells were treated with 1 mM dbcAMP with or without 1, 10, or 100 µM endothall (ENL) for 12 h. Total RNA was isolated and subjected to formaldehyde gel electrophoresis and Northern blotting. The graphs represent quantitative analysis of three experiments performed in triplicate generated from phosphorimager scanning and normalization to GAP content of each sample (n=9 per treatment group). For both graphs (B and C), the untreated control was set at 100% and is not displayed. *P<0·05 compared with control.
examined the role of PTP activity on the cAMP-dependent mRNA expression of other steroidogenic genes in H295R cells. Initially, we treated cells with PV (5 to 25 µM) in the presence and absence of dbcAMP for 12 h; however this incubation period resulted in the cells rounding up and lifting off the plates. Thus we incubated for a shorter (6 h) time period followed by RNA isolation and Northern blotting to detect steroidogenic gene mRNA expression. As shown in Fig. 3A , 6 h exposure to dbcAMP increased the accumulation of mRNA for all steroidogenic genes examined. PV was able to suppress this induction (Fig. 3B) without having any significant effect on basal expression (Fig. 3A) . Since long (12 h) exposures to PV were deleterious to the cells, we used two other PTP inhibitors (bpV and DPN) and examined their effects after 12-h incubation with and without dbcAMP. As previously observed for PV, both bpV (Posner et al. 1994) and DPN (Fujiwara et al. 1997) attenuated the cAMP-induced mRNA expression of all steroidogenic genes examined ( Fig. 4A and B respectively). At doses ranging from 0·1 to 5 µM, bpV antagonized the stimulatory effects of dbcAMP (Fig. 4A ) without any adverse affects on cell attachment. As graphically depicted, hCYP11A1 was induced 5·4-fold by dbcAMP and coadministration of 0·1, 1, and 5 µM bpV reduced this increase to 3·3-, 2·1-and 1·1-fold respectively (Fig. 4A) . Similarly, DPN (0·6 to 60 µM) inhibited the induction of all steroidogenic genes (Fig. 4B) . hCYP21 was induced 3-fold by dbcAMP and co-administration of 0·6, 6, and 60 µM DPN reduced this increase to 1·8-, 1·6-and 0·9-fold respectively. These findings indicate that tyrosine dephosphorylation is also essential for cAMPdependent steroidogenic gene expression in the human adrenal cortex.
Discussion
The transcriptional regulation of genes involved in steroid hormone biosynthesis in the adrenal cortex has been extensively studied (Waterman & Keeney 1996 , Stocco 2001 . cAMP-dependent transcription of steroid hydroxylase genes involves the activation of cAMP-dependent protein kinase A and subsequent phosphorylation of downstream target proteins. Although the requirement for the activation of PKA is well established, none of the transcription factors required for steroid hydroxylase gene transcription have been found to be PKA phosphoproteins. We have recently demonstrated that the cAMP-dependent transcription of hCYP17 in H295R cells is dependent on the activity of a dual-specificity phosphatase (DSP) . Using Northern analysis to examine endogenous hCYP17 mRNA levels and transient transfection of hCYP17 promoterreporter constructs we showed that the serine/ threonine phosphatase inhibitor OA and the phosphotyrosine phosphatase inhibitor PV both abolished cAMP-stimulated hCYP17 transcription .
In the present study we examined the effect of various selective phosphatase inhibitors on the cAMP-induced mRNA expression of several steroidogenic genes expressed in the human adrenal cortex. We found that the increase in mRNA levels evoked by dbcAMP of all steroidogenic genes examined (hCYP11A1, hCYP11B1/2, hCYP17, hCYP21, 3 HSD, and Adx) was suppressed by both serine/threonine and tyrosine selective phosphatase inhibitors. We have proposed a mechanism for hCYP17 in which the release of ACTH from the anterior pituitary results in the activation of adenylyl cyclase, and an increase in intracellular cAMP. This results, in turn, in the activation of PKA and the subsequent phosphorylation (activation) of a phosphatase, with both serine/threonine and tyrosine activity (plausibly a DSP), that is involved in maintaining optimal steroidogenic capacity . Once activated, this phosphatase removes a phosphate from SF-1 thereby activating this nuclear receptor and alleviating the repression evoked by the binding of the corepressor mSin3A to PSF . Inactivation of the mSin3A/histone deacetylase (HDAC) corepressor system then results in increased binding of the SF-1/p54 nrb / /PSF complex with the hCYP17 promoter, subsequently increasing hCYP17 gene transcription. Since SF-1 has been shown to be constitutively phosphorylated by MAP kinase (MAPK), it may be that the DSP is involved in the inactivation of the MAPK.
DSPs are a family of enzymes that were characterized as inactivators of MAPKs (Camps et al. 1999 , Keyse 2000 , Saxena & Mustelin 2000 . However, not all DSPs are active towards MAPK. VHR, another mammalian homolog, lacks an amino terminal extension identified in all other DSPs that has been shown to be important for targeting specific MAPK substrates (Ishibashi et al. 1992) . VHR has been shown to dephosphorylate growth factor receptor tyrosine kinases and notably has been found to be ineffective at dephosphorylating MAPKs (Ishibashi et al. 1992 , Shin et al. 1997 . Based on our previous findings demonstrating that a MAPK (p42 or p44) inhibition mimics the cAMP-dependent transcription of hCYP17 , we postulate that the DSP involved in ACTH/cAMP-mediated steroidogenic gene expression is active towards MAPKs. The DSPs found to inactivate MAPKs can be divided into two groups, the inducible nuclear enzymes typified by CL100/MKP1, and a second group which includes Pyst1/MKP3. The latter group are predominantly localized in the cytosol (Keyse 2000) . Due to the nuclear localization of SF-1, which we have found to be dephosphorylated in response to cAMP , we suspect that the DSP is an inducible nuclear enzyme. Interestingly, cAMP elevating agents such as forskolin and dbcAMP have been shown to induce the expression of MKP-1 (MAP kinase phosphatase-1; a nuclear DSP) in PC12 cells (Burgun et al. 2000) . Several laboratories have recently published studies demonstrating the importance of phosphatase activity in regulating the actions of ACTH/cAMP in steroidogenic cells. Paz et al. (2000) found that ACTH regulation of steroidogenesis in the rodent depends on PKA-dependent serine/threonine phosphorylation and also on the activity of protein tyrosine phosphatases. Rocchi et al. (2000) have shown that ACTH stimulates phosphotyrosine phosphatase SHP2 in bovine adrenocortical cells. SHP2 is a cytosolic protein tyrosine phosphatase that is ubiquitously expressed and has been shown to act in response to a number of different growth factors, including epidermal growth factor and platelet-derived growth factor (Feng et al. 1993 , Vogel et al. 1993 . In an in vitro kinase assay SHP2 was found to be a target for PKA (Rocchi et al. 2000) . Moreover, stimulation of 32 P-labeled bovine adrenocortical cells with ACTH resulted in increased SHP2 phosphorylation (Rocchi et al. 2000) . The findings of Rocchi et al. (2000) in bovine adrenocortical cells would suggest that only phosphotyrosine phosphatase activity mediates bovine ACTH-dependent pathways, while our present data argue for a dual function phosphatase in the human adrenal. It is also likely that the ACTH/cAMP-dependent pathways are cell-line specific.
The regulation of MAPKs (specifically p42 and p44) has also been studied in the murine adrenocortical cell line Y1 (Le & Schimmer 2001) . It was found that ACTH and basic fibroblast growth factor each increased Mek (a MAPK kinase) phosphorylation and activity (Le & Schimmer 2001) . Furthermore, PD98059 blocked the activation of p42 and p44 by ACTH (Le & Schimmer 2001) . In recent studies examining the regulation of StAR by the p42/p44 MAPKs, is was found that the forskolin-stimulated increase in steroid secretion and StAR mRNA expression in both Y1 and MA-10 (murine Leydig cell line) cells was attenuated by the Mek inhibitior PD98059 (Gyles et al. 2001) . Moreover, it was also shown that forskolin caused an increase in p42/p44 phosphorylation and translocation into the nucleus and a subsequent increase in phosphorylated SF-1 (Gyles et al. 2001) . It was hypothesized that the activation of p42/p44 by cAMP regulates steroid . We suspect that the discrepancy may be due to the difference in cell lines (murine Y1 versus human H295R). Numerous laboratories have found species-, zonal-, and cell-specific regulatory mechanisms for steroid hormone biosynthesis (Ohnishi et al. 1988 , Rodriguez et al. 1997 , Lin et al. 2001 . Our studies showing that the cAMP-inducible binding of SF-1, PSF, and p54/ to the hCYP17 promoter only occurs when using nuclear extracts isolated from H295R cells and not from Y1 cells exemplify this selectivity. cAMP-induced increases in StAR protein mRNA has also been found to be dependent upon phosphoprotein phosphatase activities (Jones et al. 2000) . Using competitive reverse transcriptionpolymerase chain reaction, it was found that inhibition of phosphoprotein phosphatase 1 and 2A activities attenuated the forskolin-induced expression of StAR mRNA (Jones et al. 2000) .
Thus, the importance of both serine/threonine and tyrosine dephosporylation is gaining attention in steroidogenesis.
In summary, we have demonstrated that the cAMP-stimulated gene expression of multiple steroidogenic genes in the human adrenal cortex is mediated by phosphatase activity. Using various selective inhibitors of either serine/threonine or tyrosine phosphatase activities, we have found that the mRNA levels of both mitochondrial and microsomal steroidogenic gene products are dependent on the activity of a DSP. Efforts are currently being made to identify this DSP that is essential for cAMP-dependent steroidogenic gene expression and also to determine if this DSP is a substrate for PKA. Our findings point to a global role for DSPs in ensuring the maintenance of optimal steroidogenic capacity in the human adrenal cortex. Data represent quantitative analysis of three experiments performed in triplicate generated from phosphorimager scanning and normalization to GAP content of each sample (n=9 per treatment group). For both graphs (A and B), untreated control was set at 100% and is not displayed. *P<0·05 compared with control. h11A1, hCYP11A1; h11B1/2, hCYP11B1/2; h17, hCYP17; h21, hCYP21.
